Detalhe da pesquisa
1.
Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan.
Biol Pharm Bull
; 46(5): 700-706, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878610
2.
Impact of regulatory interventions to restrict the combined use of renin-angiotensin system blockers: A Danish nationwide drug utilisation study.
Br J Clin Pharmacol
; 88(3): 1379-1384, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519065
3.
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
Drug Saf
; 46(7): 689-702, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294532
4.
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.
Front Pharmacol
; 14: 1207976, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37663263
5.
Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases.
Ther Innov Regul Sci
; 56(3): 474-482, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129826
6.
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products.
Paediatr Drugs
; 24(6): 679-687, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962257
7.
Medication Adherence Measurement Methods in Registration Trials Supporting the Approval of New Medicines: A Cross-Sectional Analysis of Centralized Procedures in the European Union 2010-2020.
Clin Pharmacol Ther
; 112(5): 1051-1060, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816103
8.
How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations.
Ther Innov Regul Sci
; 54(3): 577-585, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301145
9.
Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018.
BMJ Open
; 10(5): e036498, 2020 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32398337
10.
How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations.
Ther Innov Regul Sci
; : 2168479019864294, 2019 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390896
11.
Differences and similarities in medicine use, perceptions and sharing among adolescents in two different educational settings.
Int J Adolesc Med Health
; 32(2)2017 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168961